SEC Comment Letter for ADVANCED CELL TECHNOLOGY, INC. (CIK 0001140098) — Jun 27, 2005
ADVANCED CELL TECHNOLOGY, INC. (CIK 0001140098)
Date: June 27, 2005 · CIK: 0001140098 · Accession: 0000000000-05-032607
AI Filing Summary & Sentiment
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Mail Stop 3-9 May 12, 2005
A.C.T. Holdings, Inc.
381 Plantation Street
Worcester, MA 01605
Attn: William M. Caldwell
Re: A.C.T. Holdings, Inc.
Preliminary proxy statement filed May 10, 2005
File No. 0-50295
Dear Mr. Caldwell:
This is to advise you that we have monitored the subject
filing
solely with respect to proposal number 1 and have the following
comments.
1. We note that as part of this proposal, stockholders are being
asked to approve an increase in the number of authorized shares of
common stock and preferred stock of the company. As to your
common
stock, please expand the disclosure to state the number of
outstanding shares, shares reserved for issuance under option
plans,
in connection with convertible securities, etc., and the number of
shares available for issuance which have not been reserved.
2. You should disclose whether or not there are any agreements,
arrangements, plans or understandings with anyone to sell or issue
any shares of preferred stock and state the number of shares of
each
class or series of preferred stock authorized and the number of
shares outstanding, if any.
As appropriate, please amend your filing in response to these
comments. If you disagree, we will consider your explanation as
to
why a comment is inapplicable or a revision is unnecessary.
Please
be as detailed as necessary in your explanation.
Any questions should be directed to Michael Reedich at (202)
942-1815, or the undersigned at (202) 942-1840.
Sincerely,
Jeffrey Riedler
Assistant Director
??
??
??
??
1
</TEXT>
</DOCUMENT>